- Drug Pipelines
- February 2022
- 154 Pages
Global
From €5477EUR$5,700USD£4,702GBP
- Report
- January 2022
- 200 Pages
Global
From €7206EUR$7,500USD£6,186GBP
- Report
- January 2022
- 60 Pages
Global
From €3795EUR$3,950USD£3,258GBP
- Report
- January 2022
- 60 Pages
Global
From €3795EUR$3,950USD£3,258GBP
- Report
- September 2018
- 630 Pages
Global
From €21139EUR$22,000USD£18,146GBP
- Report
- March 2022
- 120 Pages
Global
From €2402EUR$2,500USD£2,062GBP
- Report
- August 2022
United States
From €1864EUR$1,940USD£1,600GBP
- Report
- August 2022
Global
From €1143EUR$1,190USD£982GBP
- Report
- August 2021
Global
From €3834EUR$3,990USD£3,291GBP
- Report
- August 2021
Europe
From €3286EUR$3,420USD£2,821GBP
- Report
- February 2021
Global
From €2844EUR$2,960USD£2,442GBP
- Report
- June 2022
- 53 Pages
Global
From €3839EUR$3,995USD£3,295GBP
- Report
- November 2019
- 47 Pages
Global
From €3839EUR$3,995USD£3,295GBP
- Report
- April 2020
- 153 Pages
Global
From €10564EUR$10,995USD£9,069GBP
- Drug Pipelines
- June 2020
- 3889 Pages
Global
From €2402EUR$2,500USD£2,062GBP
- Report
- November 2020
- 265 Pages
Global
From €3843EUR$4,000USD£3,299GBP
- Report
- January 2022
- 200 Pages
Global
From €7206EUR$7,500USD£6,186GBP
- Newsletter
- May 2024
Global
From €1010EUR$1,126USD£897GBP
- Report
- May 2021
- 88 Pages
Global
€21139EUR$22,000USD£18,146GBP
- Report
- February 2024
- 88 Pages
Global
From €3500EUR$3,902USD£3,110GBP
The Colorectal Cancer Drug market is composed of drugs used to treat colon cancer. These drugs are used to reduce the size of tumors, reduce the spread of cancer cells, and reduce the risk of recurrence. Commonly used drugs include chemotherapy, targeted therapy, immunotherapy, and hormone therapy. Chemotherapy is the most common treatment for colon cancer, and is used to kill cancer cells. Targeted therapy is used to target specific molecules in cancer cells, while immunotherapy is used to boost the body’s immune system to fight cancer. Hormone therapy is used to reduce the production of hormones that can cause cancer cells to grow.
Companies in the Colorectal Cancer Drug market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Pfizer, and Roche. Show Less Read more
